PINEHURST – A FirstHealth Moore Regional Hospital clinical trial is investigating whether the electrical treatment provided by a special type of pacemaker can keep a patient in heart failure from getting worse.
The Cardiac Resynchronization Therapy (CRT) pacemaker being studied in this clinical trial has been approved by the U.S. Food and Drug Administration (FDA) for patients with moderate to severe heart failure whose heart pumps blood inefficiently. The study will determine if blood can be pumped to the body more efficiently when the lower heart chambers (i.e. ventricles) are electrically paced to beat together by the CRT pacemaker.
Cardiac resynchronization therapy (CRT) can help restore a normal coordinated heart rhythm by delivering pacing treatment to both sides of the heart.
Participants in the trial will be men and women 18 years and older with a diagnosis of chronic heart failure. Pregnant women are not eligible.
Mark Landers, M.D., a cardiologist with FirstHealth Cardiology Services, is the principal investigator.
To refer a patient for this trial or for more information on patient eligibility, contact the FirstHealth Clinical Trials office at (910) 715-2200.
December 1, 2016
Montgomery County Schools First in Nation to Implement Daily Mile ProgramRepresentatives of the various agencies involved in the Montgomery County implementation of The Daily Mile prepare to cut the ribbon for the walking…
October 4, 2016
Stand Together & Drink PinkRegister in the form provided to host your Drink Pink lemonade stand. To learn more about the Stand Together & Drink Pink campaign, click here. To do…
October 4, 2016
Stand Together & Drink PinkIf you are interested in a different, and tasty, way of increasing breast cancer awareness, join in as the community prepares to “Stand Together and…
December 8, 2016
CME: Esophageal Cancer UpdateYou are invited to attend a program Esophageal Cancer Update December 8, 2016 Dinner at 5:45 p.m. • Program to follow at 6:15 p.m. Conference Center…